Introduction
Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the protective covering of nerve fibers in the central nervous system. This damage can lead to relapses, disability progression, and a wide range of neurological symptoms that affect mobility, vision, balance, and daily functioning.
Mayzent is an oral disease-modifying therapy approved to treat relapsing forms of multiple sclerosis in adults. By reducing inflammatory activity within the central nervous system, Mayzent helps decrease disease activity and may help slow disability progression in patients with active secondary progressive multiple sclerosis.
Because Mayzent is a specialty prescription medication, treatment costs can be high. Many people searching for a Mayzent patient assistance program are looking for ways to reduce their prescription expenses. Prescription assistance programs, such as those accessed through Prescription Hope, may help eligible patients obtain Mayzent at a more affordable cost.
What Is the Mayzent Patient Assistance Program?
Understanding Mayzent Prescription Assistance
Pharmaceutical manufacturers have come to recognize the financial strain that brand-name medications can cause struggling Americans. Some of these manufacturers have enacted a plan to help patients who need their medication. The solution is a patient assistance program, such as the Mayzent patient assistance program. This allows qualified patients to have access to the medications they need at a lower cost than they would through the market rate, affording them help paying for Mayzent.
However, these patient assistance programs are known to require a lot of time and paperwork, which can be frustrating or upsetting for some patients.
Prescription Hope can help with that.
How Expert Advocates Help Make Mayzent More Affordable
Personalized Medication Assistance
Prescription Hope is here to provide you with Mayzent enrollment assistance so that you can focus on your treatment needs and quality of life. We understand how extensive paperwork can get in the way of the things that matter, and our compassionate prescription assistance specialists are there to assist you every step of the way. Some of our patient support services throughout the application process include taking care of forms, documents, and signatures, communication with healthcare providers, coordinating with manufacturers, and more.
Ongoing Patient Support
Prescription Hope isn’t just here to help you apply to patient assistance programs. We help you maintain long-term medication assistance for as long as you are a patient with us. Some of the ways we provide specialty medication assistance throughout the course of your treatment continuity are refill scheduling, document updates, yearly renewals, program monitoring, and more.
Mayzent Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Multiple Sclerosis Treatment Costs
MS treatment affordability doesn’t have to be a confusing process. Mayzent cost assistance is just one of the modes of specialty medication support services Prescription Hope offers its qualified patients.
Even if you get approved for a different medication, we will help qualified patients gain access to it for the low monthly fee of $70.00 per month, per medication. This price means no hassles, hidden fees, add-ons, or medication costs, and all of Prescription Hope’s prescription cost help at your disposal.
Even if you don’t qualify for a prescription assistance program, our team will still help you find ways to save, such as substitute medications, discount cards, and coupons. If we can’t help you save money on your name-brand medication, you pay us nothing.
Mayzent Patient Assistance Eligibility
General Eligibility Requirements
If you are a patient interested in Mayzent cost assistance, please read further for information on Mayzent patient assistance qualifications. Prescription Hope is a good resource for information on who qualifies for Mayzent assistance, but most programs will set patient requirements in several different categories. Some of those typically include:
Income: Patient assistance programs will set their own requirements for a patient’s income threshold.
Insurance: Patient assistance programs will also set their own requirements for a patient’s insurance coverage status.
Prescription: Qualified patients must hold a valid prescription for the name-brand medication they seek to obtain.
U.S. Residency: Qualified patients must be legal residents of the U.S.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Are you ready to enroll in Mayzent assistance? Are you concerned about the Mayzent application process? Prescription support services through Prescription Hope are here for you in 6 easy steps:
- Submit Information: Our online enrollment form can be completed in just a few minutes.
- Advocate Contact: After we receive your enrollment form, a patient advocate will reach out to you in 1-2 business days.
- Document Collection: After your prequalification goes through, our team will connect with you to get any needed documents.
- Provider Coordination: Our team will also speak with your healthcare provider to get hold of any necessary signatures.
- Program Submission: After all the paperwork is put in order by our team and sent in on your behalf, we will continue to coordinate with the pharmaceutical manufacturer for you.
- Medication Delivery: Your medication will normally arrive in the mail in 2 weeks after approval.
Prescription Hope is not a pharmacy or pharmaceutical manufacturer, and therefore does not handle any medications. All medications are shipped from the pharmaceutical manufacturer to the qualified patient’s door or healthcare provider.
Understanding Mayzent
How Mayzent Works
Mayzent is a selective sphingosine 1-phosphate (S1P) receptor modulator that binds to S1P receptor subtypes 1 and 5.
Mayzent selectively modulates S1P receptors 1 and 5, preventing lymphocytes from exiting lymph nodes and reducing their migration into the central nervous system, where they contribute to inflammatory damage. This helps reduce inflammation and nerve damage associated with multiple sclerosis. Activity at the S1P5 receptor may also support cells involved in maintaining myelin, although the clinical significance of this effect has not been established.
What Conditions Does Mayzent Treat?
Mayzent is FDA-approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including:
- Clinically isolated syndrome (CIS)
- Relapsing-remitting disease (RRMS)
- Active secondary progressive disease (active SPMS)
Mayzent is indicated to help reduce disease activity and may help slow disability progression in patients with active secondary progressive multiple sclerosis.
Benefits of Treatment
For appropriate patients with relapsing forms of multiple sclerosis, Mayzent may:
- Reduce the frequency of MS relapses
- May help slow disability progression in patients with active secondary progressive MS
- Reduce the number of new or enlarging brain lesions seen on MRI
- Help decrease inflammatory disease activity
- Offer a convenient once-daily oral treatment option
Individual treatment responses vary, and ongoing monitoring is required throughout therapy.
Important Safety Information and Side Effects
Mayzent does not carry an FDA Boxed Warning.
Contraindications
Mayzent is contraindicated in patients who:
- Have the **CYP2C93/3 genotype
- Experienced any of the following within the previous 6 months:
- Myocardial infarction (heart attack)
- Unstable angina
- Stroke
- Transient ischemic attack (TIA)
- Decompensated heart failure requiring hospitalization
- Class III or IV heart failure
- Have certain untreated cardiac conduction abnormalities unless they have a functioning pacemaker, including:
- Mobitz type II second-degree atrioventricular (AV) block
- Third-degree AV block
- Sick sinus syndrome
The most commonly reported side effects include:
- Headache
- High blood pressure (hypertension)
- Elevated liver enzymes
- Falls
- Swelling of the arms or legs (peripheral edema)
- Nausea
Common laboratory abnormalities include:
- Reduced lymphocyte count (lymphopenia)
- Elevated liver function tests
Patients should notify their healthcare provider if side effects become severe or persistent.
Patients should discuss the following risks with their healthcare provider:
- Increased risk of serious infections due to reduced lymphocyte counts
- Bradyarrhythmia and slowed heart rate after the first dose
- Elevated liver enzymes and liver injury
- Macular edema
- Increased blood pressure
- Decline in lung function, particularly in susceptible patients
- Posterior reversible encephalopathy syndrome (PRES)
- Severe worsening of disease after discontinuation
- Cutaneous malignancies, including basal cell carcinoma, squamous cell carcinoma, and melanoma
- Fetal harm if used during pregnancy
Before starting treatment, patients require:
- CYP2C9 genotype testing
- A recent complete blood count (CBC)
- Liver function tests
- Ophthalmic evaluation when appropriate
- Verification of varicella-zoster virus immunity if there is no history of infection or vaccination
First-dose cardiac monitoring is recommended for certain patients at increased risk of bradycardia.
Mayzent may cause fetal harm when administered during pregnancy. A negative pregnancy test is recommended before treatment initiation in females of reproductive potential. Females of reproductive potential should use effective contraception during treatment and for at least 10 days after the final dose. Patients should notify their healthcare provider immediately if pregnancy occurs.
It is not known whether siponimod is present in human breast milk. Because of the potential for serious adverse reactions, breastfeeding is generally not recommended during treatment and for at least 10 days after the last dose.
Mayzent may interact with:
- Antiarrhythmic medications
- QT-prolonging medications
- Heart rate-lowering medications, including beta blockers, certain calcium channel blockers, and digoxin
- Other immunosuppressive or immune-modulating therapies
- Live attenuated vaccines
- CYP2C9 inhibitors and inducers
- Moderate CYP2C9 inhibitors used with moderate or strong CYP3A4 inhibitors
- Strong CYP3A4 inducers in certain CYP2C9 genotypes
Because siponimod metabolism depends on CYP2C9 genotype, dosing recommendations and drug interactions vary according to genotype.
Mayzent is taken orally once daily and is available as 0.25 mg and 2 mg tablets. Treatment requires a 5-day dose titration when initiating therapy, and the maintenance dose depends on the patient’s CYP2C9 genotype. It may be taken with or without food. CYP2C9 genotype testing must be completed before treatment begins, and certain patients require first-dose cardiac monitoring. If treatment is interrupted for 4 or more consecutive daily doses, therapy must be restarted using the 5-day titration regimen.
Access to Multiple Medications
Support Beyond Mayzent
Patients who are looking for multiple sclerosis medication assistance may need access to multiple medication assistance programs, due to their ongoing need for specialty medication support. Prescription Hope can help provide access to name-brand medications so that our qualified patients can focus on the things that matter, like their treatment and loved ones.
This service is available for hundreds of brand-name medications and their associated patient assistance programs through Prescription Hope. Every medication a patient needs access to can be obtained through Prescription Hope for the same simple cost of $70.00 per month, per medication.
Why Choose Prescription Hope
Patient-Focused Medication Support
Since 2006, Prescription Hope has offered qualified patients across America prescription affordability support and patient-centered prescription help. We’re proud to offer Mayzent assistance services through Prescription Hope.
Simplified Access to Prescription Medications
Prescription Hope offers medication access support and patient assistance services for $70.00 per month, per medication. There are no hidden fees, add-ons, or hidden charges.
Ongoing Prescription Assistance
All of our medication assistance support doesn’t just stop after you’ve gained access to prescription affordability programs. We also offer long-term medication support by completing administrative tasks required to stay in a patient assistance program, such as refill scheduling, yearly renewals, document updates, program monitoring, and more.
Network Access
Prescription Hope’s network reaches across America, offering access to hundreds of name-brand medications and their associated patient assistance programs to patients from big cities to rural areas.
If you need Mayzent and you’re worried about the financial strain it may place on you, enroll with Prescription Hope to see how you can save money today.